Aviva’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,181
Closed -$570K 870
2024
Q4
$570K Sell
5,181
-648
-11% -$74.2K ﹤0.01% 755
2024
Q3
$659K Buy
5,829
+897
+18% +$104K ﹤0.01% 733
2024
Q2
$610K Sell
4,932
-71
-1% -$8.89K ﹤0.01% 765
2024
Q1
$645K Sell
5,003
-495
-9% -$60.1K ﹤0.01% 786
2023
Q4
$678K Sell
5,498
-252
-4% -$26.8K ﹤0.01% 752
2023
Q3
$588K Sell
5,750
-8,503
-60% -$889K ﹤0.01% 795
2023
Q2
$1.43M Buy
14,253
+5,003
+54% +$501K 0.01% 741
2023
Q1
$950K Buy
+9,250
New +$995K ﹤0.01% 861
2022
Q2
Sell
-7,860
Closed -$727K 1079
2022
Q1
$727K Sell
7,860
-21,053
-73% -$1.99M ﹤0.01% 1001
2021
Q4
$2.61M Buy
28,913
+10,271
+55% +$907K 0.01% 771
2021
Q3
$1.57M Buy
+18,642
New +$1.66M 0.01% 872

Other funds holding IOSP

Aviva's IOSP Position: Q1 2025 in Review

Aviva sold out of Innospec (IOSP) in Q1 2025, closing a stake of 5,181 shares — an estimated $570K sold.

Aviva first reported a position in IOSP in Q3 2021 and held it in 11 quarters. The position peaked at $2.61M in Q4 2021. 272 funds tracked by Wall St. Rank hold IOSP as of Q1 2025.

  • Aviva reported no remaining Innospec position as of Q1 2025 after selling out during the quarter.
  • Aviva sold 5,181 Innospec shares in Q1 2025, an estimated $570K.
  • Aviva first reported a position in Innospec in Q3 2021 and held it in 11 quarters.
  • Aviva's Innospec position peaked at $2.61M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held Innospec as of Q1 2025.

Based on Aviva's 13F filing for Q1 2025, filed 15 May 2025.